ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Apogee Therapeutics Inc

Apogee Therapeutics Inc (APGE)

36.37
-2.62
(-6.72%)
Closed June 20 4:00PM
36.40
0.03
(0.08%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
36.37
Bid
36.40
Ask
36.60
Volume
945,649
36.26 Day's Range 39.33
14.19 52 Week Range 72.29
Market Cap
Previous Close
38.99
Open
39.13
Last Trade
5
@
36.5
Last Trade Time
Financial Volume
$ 35,288,776
VWAP
37.317
Average Volume (3m)
429,193
Shares Outstanding
50,655,671
Dividend Yield
-
PE Ratio
-21.97
Earnings Per Share (EPS)
-1.66
Revenue
-
Net Profit
-83.99M

About Apogee Therapeutics Inc

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Apogee Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker APGE. The last closing price for Apogee Therapeutics was $38.99. Over the last year, Apogee Therapeutics shares have traded in a share price range of $ 14.19 to $ 72.29.

Apogee Therapeutics currently has 50,655,671 shares outstanding. The market capitalization of Apogee Therapeutics is $1.85 billion. Apogee Therapeutics has a price to earnings ratio (PE ratio) of -21.97.

APGE Latest News

Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...

Apogee Therapeutics to Participate in Upcoming June Investor Conferences

SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-7.02-16.178843051443.3945.9736.2634899241.69608249CS
4-15.57-29.976896418951.9452.0736.2637442544.5746042CS
12-27.83-43.348909657364.269.436.2642919352.09210721CS
2613.559.02929602122.8772.2922.253045951.45336815CS
5214.8769.162790697721.572.2914.1943821440.42227326CS
15614.8769.162790697721.572.2914.1943821440.42227326CS
26014.8769.162790697721.572.2914.1943821440.42227326CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.35M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.36M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M